Claims Reimbursement

FDA Approves Biogen’s Alzheimer’s Drug; UHC to Not Pay for Unnecessary ED Visits

June 8, 2021 - A heatwave has many across the country seeking shelter for a different reason. Stay cool out there! FDA APPROVES BIOGEN’S ALZHEIMER’S DRUG AFTER DEBATE The FDA has officially approved aducanumab, Biogen’s drug for Alzheimer’s Disease, the agency has announced. This marks the first Alzheimer’s drug in nearly 20 years...


More Articles

Do Not Sell or Share My Personal Information
©2012-2024 TechTarget, Inc. Xtelligent Healthcare Media is a division of TechTarget. All rights reserved. HealthITAnalytics.com is published by Xtelligent Healthcare Media a division of TechTarget.